0001410939-22-000120.txt : 20221205 0001410939-22-000120.hdr.sgml : 20221205 20221205173737 ACCESSION NUMBER: 0001410939-22-000120 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221201 FILED AS OF DATE: 20221205 DATE AS OF CHANGE: 20221205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Westby Keith CENTRAL INDEX KEY: 0001696429 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36080 FILM NUMBER: 221446014 MAIL ADDRESS: STREET 1: ONE UNIVERSITY SQUARE DRIVE, SUITE 280 CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IVERIC bio, Inc. CENTRAL INDEX KEY: 0001410939 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208185347 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: (609) 474-6755 MAIL ADDRESS: STREET 1: 8 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 FORMER COMPANY: FORMER CONFORMED NAME: Ophthotech Corp. DATE OF NAME CHANGE: 20070828 4 1 wf-form4_167027983493997.xml FORM 4 X0306 4 2022-12-01 0 0001410939 IVERIC bio, Inc. ISEE 0001696429 Westby Keith C/O IVERIC BIO, INC. 8 SYLVAN WAY PARSIPPANY NJ 07054 0 1 0 0 SVP & COO Common Stock 2022-12-01 4 S 0 10030 22.96 D 59759 D Common Stock 2022-12-02 4 M 0 5199 10.03 A 64958 D Stock Option (right to buy) 10.03 2022-12-02 4 M 0 5199 10.03 D 2022-12-29 Common Stock 5199.0 0 D The sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2021. The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $22.62 to $23.84 per share on December 1, 2022. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range. This total includes 661 shares acquired by the Reporting Person on September 15, 2022 under the Registrant's 2016 Employee Stock Purchase Plan that were not previously reported. This option was granted on December 29, 2012 and is currently excisable for all shares underlying the option. /s/ Todd D.C. Anderman, as Attorney-in-Fact for Keith Westby 2022-12-05